Maravai LifeSciences Holdings, Inc. MRVI Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s accrued expenses?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported accrued expenses of $28.65M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s accrued expenses changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s accrued expenses decreased by 35.8% year-over-year, from $44.6M to $28.65M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s accrued expenses has grown at a -1.0% compound annual growth rate (CAGR), from $38.55M to $36.57M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.